These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7741492

  • 1. Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
    Au E, Tow A, Allen DM, Ang PT.
    Ann Acad Med Singap; 1994 Nov; 23(6):819-22. PubMed ID: 7741492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients.
    Shah PM, Heller A, Fuhr HG, Walther F, Halir S, Schaumann R, Böhme A, Jung B, Köhler A, Lips-Schulte C, Stille W.
    Infection; 1996 Nov; 24(6):480-4. PubMed ID: 9007599
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients.
    Liu CY, Wang FD.
    Chemotherapy; 1989 Nov; 35 Suppl 2():16-22. PubMed ID: 2692982
    [Abstract] [Full Text] [Related]

  • 6. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
    Petrilli AS, Melaragno R, Barros KV, Silva AA, Kusano E, Ribeiro RC, Bianchi A.
    Pediatr Infect Dis J; 1993 Nov; 12(11):916-21. PubMed ID: 8265281
    [Abstract] [Full Text] [Related]

  • 7. Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
    Biron P, Fuhrmann C, Cure H, Viens P, Lefebvre D, Thyss A, Viot M, Soler-Michel P, Rollin C, Grès JJ.
    J Antimicrob Chemother; 1998 Oct; 42(4):511-8. PubMed ID: 9818751
    [Abstract] [Full Text] [Related]

  • 8. A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.
    Kojima A, Shinkai T, Soejima Y, Okamoto H, Eguchi K, Sasaki Y, Tamura T, Oshita F, Ohe Y, Saijo N.
    Am J Clin Oncol; 1994 Oct; 17(5):400-4. PubMed ID: 8092111
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
    Figuera A, Rivero N, Pajuelo F, Font P, Leyra F, de La Cámara R, Arranz R, María Fernández Rañada J.
    Med Clin (Barc); 2001 May 05; 116(16):610-1. PubMed ID: 11412645
    [Abstract] [Full Text] [Related]

  • 10. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
    Gorschlüter M, Hahn C, Fixson A, Mey U, Ziske C, Molitor E, Horré R, Sauerbruch T, Marklein G, Schmidt-Wolf IG, Glasmacher A.
    Support Care Cancer; 2003 Jun 05; 11(6):362-70. PubMed ID: 12690546
    [Abstract] [Full Text] [Related]

  • 11. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Sanz MA, Bermúdez A, Rovira M, Besalduch J, Pascual MJ, Nocea G, Sanz-Rodríguez C, COSTINE Study Group.
    Curr Med Res Opin; 2005 May 05; 21(5):645-55. PubMed ID: 15969864
    [Abstract] [Full Text] [Related]

  • 12. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
    Liang R, Yung R, Chiu E, Chau PY, Chan TK, Lam WK, Todd D.
    Antimicrob Agents Chemother; 1990 Jul 05; 34(7):1336-41. PubMed ID: 2201252
    [Abstract] [Full Text] [Related]

  • 13. Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
    Ozyilkan O, Yalçintaş U, Başkan S.
    Korean J Intern Med; 1999 Jul 05; 14(2):15-9. PubMed ID: 10461420
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections.
    Danziger LH, Creger RJ, Shwed JA, Stellato TA, Hau T.
    Pharmacotherapy; 1988 Jul 05; 8(6):315-8. PubMed ID: 3222164
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.
    Norrby SR, Eriksson M, Ottosson E.
    Scand J Infect Dis; 1986 Jul 05; 18(4):371-4. PubMed ID: 3094139
    [Abstract] [Full Text] [Related]

  • 18. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
    Romanelli G, Cravarezza P, Pozzi A, Franchino L, Ravizzola G, Zulli R, Donati P, Prometti P, Grassi V.
    J Chemother; 2002 Dec 05; 14(6):609-17. PubMed ID: 12583553
    [Abstract] [Full Text] [Related]

  • 19. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.
    Karadeniz C, Oğuz A, Canter B, Serdaroğlu A.
    Pediatr Hematol Oncol; 2000 Dec 05; 17(7):585-90. PubMed ID: 11033734
    [Abstract] [Full Text] [Related]

  • 20. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
    Mortimer J, Miller S, Black D, Kwok K, Kirby WM.
    Am J Med; 1988 Jul 25; 85(1A):17-20. PubMed ID: 3400679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.